Master has made over 1 trades of the IGC Pharma Inc stock since 2008, according to the Form 4 filled with the SEC. Most recently Master sold 11,447 units of IGC stock worth $66,965 on 22 February 2008.
The largest trade Master's ever made was selling 11,447 units of IGC Pharma Inc stock on 22 February 2008 worth over $66,965. On average, Master trades about 3,816 units every 0 days since 2008.
You can see the complete history of Master Nisswa stock trades at the bottom of the page.
Master's mailing address filed with the SEC is C/O PINE RIVER CAPITAL MANAGEMENT L.P., 601 CARLSON PARKWAY, SUITE 330, MINNETONKA, MN, 55305.
Over the last 17 years, insiders at IGC Pharma Inc have traded over $12,397,736 worth of IGC Pharma Inc stock and bought 1,543,722 units worth $473,972 . The most active insiders traders include Ram Mukunda, Steven Michael Oliveira e Zwirn & Co., L.P.Zwirn Dani.... On average, IGC Pharma Inc executives and independent directors trade stock every 143 days with the average trade being worth of $93,624. The most recent stock trade was executed by Ram Mukunda on 13 March 2024, trading 1,184,585 units of IGC stock currently worth $443,627.
igc is developing a product portfolio of phytocannabinoid-based therapies through leading edge research for the treatment of a wide range of therapeutic indications. these include neuropathic and cancer pain, epilepsy, end of life supportive care, adjunctive supportive therapies of chronic neurological and oncological diagnosis, which are life altering or life threatening our mission is to treat pain, ptsd, seizures, cachexia, chronic and terminal neurological and oncological diagnoses, and other life altering conditions with phytocannabinoid-based treatments
IGC Pharma Inc executives and other stock owners filed with the SEC include: